TABLE 5.
Explanatory variable | 1-yr IL-2+ SFC |
1-yr IFN-γ+ SFC |
1-yr IFN-γ+ IL-2+ SFC |
|||
---|---|---|---|---|---|---|
RCE | P | RCE | P | RCE | P | |
Age | −1.35 | 0.02 | −1.50 | 0.001 | −1.09 | 0.003 |
Baseline responses | 0.74 | <0.001 | 0.80 | <0.001 | 0.79 | <0.001 |
CD4+ IL-10+ | −1.46 | 0.9 | 2.72 | 0.78 | 0.77 | 0.92 |
CD8+ IL-10+ | 9 | 0.38 | 1.26 | 0.88 | 3.56 | 0.6 |
CD4+ FOXP3+ CD25+ | 19.11 | 0.68 | −25.43 | 0.50 | −7.93 | 0.79 |
CD8+ FOXP3+ CD25+ | −37.26 | 0.28 | −6.18 | 0.83 | −10.35 | 0.65 |
CD4+ FOXP3+ | −24.33 | 0.02 | −10.63 | 0.23 | −10.89 | 0.12 |
CD8+ FOXP3+ | 8.29 | 0.55 | 0.51 | 0.96 | 0.23 | 0.98 |
CD4+ TGF-β+ | 15.38 | 0.08 | 6.99 | 0.34 | 8.1 | 0.17 |
CD8+ TGF-β+ | −1.60 | 0.78 | 3.13 | 0.51 | 1.07 | 0.78 |
CD4+ CD28− CD57+ | −0.249 | 0.77 | −0.02 | 0.98 | −0.01 | 0.98 |
CD8+ CD28− CD57+ | −0.72 | 0.07 | −0.44 | 0.18 | −0.41 | 0.12 |
CD4+ PD1+ | 5.15 | 0.31 | 5.74 | 0.17 | 3.82 | 0.26 |
CD8+ PD1+ | −10.34 | 0.02 | −6.96 | 0.05 | −6.19 | 0.03 |
CD4+ CD31+ | −15.97 | 0.06 | −14.02 | 0.05 | −11.74 | 0.04 |
CD8+ CD31+ | 6.69 | 0.42 | 7.83 | 0.25 | 5.85 | 0.29 |
Boldface type indicates statistically significant effects defined by a P value of <0.02 to adjust for multiple comparisons. Abbreviations: VZV, varicella-zoster virus; Th1, T helper 1; SFC, spot-forming cells/106 PBMC; RCE, regression coefficient estimate (indicates the magnitude of the difference); baseline responses, prevaccination responses in the same category as the outcome measure (e.g., prevaccination IFN-γ SFC as an explanatory variable for peak IFN-γ SFC or prevaccination IL-2 SFC as an explanatory variable for peak IL-2 SFC, etc.).